Frisco, TX (PRWEB) July 14, 2011
SomnoMed, Inc., the global leader in oral sleep appliance technology, will host a two-day educational course Aug. 5-6 in Chicago to help dentists successfully implement Dental Sleep Medicine within their practices. The SomnoMed Academy course will introduce dentists to screening and treating patients with Obstructive Sleep Apnea (OSA) through extensive educational and hands-on sessions designed to maximize the latest dental sleep medicine technologies and develop streamlined protocols.
Sleep issues are not new – in fact, the 2002 National Sleep Foundation (NSF) Sleep in America poll found that 74 percent of American adults are experiencing a sleeping problem a few nights a week or more, 39 percent get less than seven hours of sleep each weeknight, and 37 percent are so sleepy during the day that it interferes with daily activities.
Sleep apnea, considered a sleeping disorder, affects tens of millions of Americans and is associated with obesity, diabetes, high blood pressure, increased risk of heart attack, stroke, memory/performance problems, depression and higher accident rates. SomnoMed’s SomnoDent® is a custom-made oral device that positions the lower jaw slightly forward of its usual position. This has the effect of keeping the airway open, preventing snoring and treating the serious chronic condition of OSA.
“SomnoDent is a unique solution for treating OSA that has unprecedented compliance rates among patients,” said Anthony White, vice president of marketing and SomnoMed Academy. “We look forward to helping dentists introduce this solution in their practices to help patients sleep better, which in turn creates an overall healthier lifestyle.”
Registration for SomnoMed Academy is limited, and participants who reserve their seat before July 15 will receive a free demonstration model. For more information about SomnoMed Academy, visit http://www.somnomed.com.
SomnoMed, Inc. is the world’s leading company in dental sleep medicine with expanding operations in North America, Europe, Asia-Pacific and Japan. As the Gold Standard in oral appliance treatment of sleep disordered breathing, the SomnoDent® device offers a clinically proven, effective and compliant alternative treatment for the majority of patients experiencing mild to moderate Obstructive Sleep Apnea (OSA) – and for existing CPAP therapy patients looking for improved comfort and compliance. North America is the largest worldwide market in Sleep Medicine, with more than 40 million Americans suffering from sleep disorders, according to the National Sleep Foundation. For additional information, visit SomnoMed at http://www.SomnoMed.com.